Ono will secure exclusive rights to develop and commercialize Biohaven’s MoDE pan-IgG degrader portfolio in Japan, South ...

The randomized, double-blind, placebo-controlled trial included 233 evaluable patients across 11 US cancer centers ...

Global healthcare company Viatris has agreed to acquire Pacira BioSciences for $1.65 billion in an all-cash deal, strengthening its position in the growing non-opioid pain treatment market.

Cadila Pharmaceuticals, one of India’s top global drug manufacturers, has officially entered the Asia Book of Records. The ...

Lonza and Asimov have announced a strategic collaboration aimed at advancing lentiviral vector (LVV) manufacturing for ...

Jubilant Draximage Inc. is investing CAD 94.5 million to modernize and expand its facility in Kirkland, Québec. The expansion ...

His remarks underscored the need to strengthen India's capabilities in drug development, biosimilars and pharmaceutical ...

The country’s population aged 60 years and above is projected to rise from around 153 million in 2022 to approximately 347 ...

Nearly 25% of all colon cancers are diagnosed at stage III, and almost one in three patients with stage III colon cancer ...

BMS said the safety profile of ZENBEXUS in combination with standard therapies was consistent with previously reported ...

Global pharma major Lupin Limited announced that it has received approval from the United States Food and Drug Administration ...

Eli Lilly has said that its once-daily oral drug Foundayo (orforglipron) 17.2 mg was associated with greater weight loss and ...